<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0192030.ref051">
 <label>51</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Rangaka</surname>
   <given-names>MX</given-names>
  </name>, 
  <name>
   <surname>Wilkinson</surname>
   <given-names>RJ</given-names>
  </name>, 
  <name>
   <surname>Boulle</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Glynn</surname>
   <given-names>JR</given-names>
  </name>, 
  <name>
   <surname>Fielding</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>van Cutsem</surname>
   <given-names>G</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial</article-title>. 
  <source>Lancet</source>. 
  <year>2014</year>;
  <volume>384</volume>(
  <issue>9944</issue>):
  <fpage>682</fpage>â€“
  <lpage>90</lpage>. Epub 2014/05/20. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S0140-6736(14)60162-8" xmlns:xlink="http://www.w3.org/1999/xlink">10.1016/S0140-6736(14)60162-8</ext-link>
  </comment>
  <?supplied-pmid 24835842?>
  <pub-id pub-id-type="pmid">24835842</pub-id>
 </mixed-citation>
</ref>
